MedPath

Glenohumeral Cortisone Injection

Phase 2
Completed
Conditions
Humeral Fractures
Interventions
Registration Number
NCT04216017
Lead Sponsor
University of Washington
Brief Summary

The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.

Detailed Description

THis is a randomized control trial to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria

1.18-90

  1. Proximal Humerus Fracture

  2. Decreased range of motion at 6 wk follow-up

  3. Likely to be available for follow up for 26 wks

Read More
Exclusion Criteria
  1. Known drug allergy to kenalog or lidocaine
  2. Unable to complete functional outcome
  3. Pregnant Women
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlsLidocainePatients receiving lidocaine
CaseskenalogPatients receiving Kenalog
Primary Outcome Measures
NameTimeMethod
American Shoulder Elbow Society Score24 weeks

Outcome Instrument high is good low is bad 0-100 The ASES is a condition-specific scale that is intended to measure functional limitations and pain of the shoulder.

Secondary Outcome Measures
NameTimeMethod
Visual Analogue Scale24 weeks

pain scale - high is bad - low is good 0-100

Trial Locations

Locations (1)

University of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath